About
Innovo Mimetics specializes in anti-cancer therapy efficacy assays in the well-established chick egg tumor xenograft model. This model is based on the ability of a fertilized chick egg to engraft and nourish foreign cells, including cancer cells, that are placed in the egg. Innovo's proprietary assay system, ScreenOvo, allows rapid and low-cost evaluation of chemical, biological, and cell therapies. The advantages of the ScreenOvo Assay include a living tumor at low cost; a complete assay in 14 days; and broad applicability for testing immune cell therapies, checkpoint inhibition, and anti-cancer drug efficacy. ScreenOvo is designed as a service tool for immunotherapy and pharmaceutical companies to deliver xenograft tumor data in the chick egg model in order to expand the cancer therapy pipeline, generate proofs of concept for new innovations, screen for lead products, and reduce research risk before heavily investing in mouse models. ScreenOvo offers cancer cell recognition and killing, tumor infiltration, antibody-dependent cellular cytotoxicity, and checkpoint inhibition.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Innovo Mimetics?
- Innovo Mimetics specializes in anti-cancer therapy efficacy assays using a chick egg tumor xenograft model.
- What is the status of Innovo Mimetics as of December 2024?
- Innovo Mimetics is currently inactive, having ceased operations in December 2024.
- What is the name of Innovo Mimetics' proprietary assay system?
- Innovo Mimetics' proprietary assay system is called ScreenOvo.
- What is the total amount of funding Innovo Mimetics has raised?
- Innovo Mimetics has raised a total of $160,000 in funding. For a full financing history, refer to startupim.
- When was Innovo Mimetics founded?
- Innovo Mimetics was founded in March 2010.
- How many employees did Innovo Mimetics have?
- Innovo Mimetics had 8 employees.
- What grants did Innovo Mimetics receive?
- Innovo Mimetics received grants from the IIA in August 2017 and July 2015.
- Where is Innovo Mimetics headquartered?
- Innovo Mimetics is headquartered in Jerusalem, Israel.
- What is the current stage of Innovo Mimetics?
- Innovo Mimetics' current stage is Seed.